Cargando…
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
Preoperative chemo- and radiotherapeutic strategies followed by surgery are currently a standard approach for treating locally advanced gastric and esophagogastric junction cancer in Western countries. However, in a large number of cases, the tumor is extremely resistant to these treatments and the...
Autores principales: | Cavaliere, Alessandro, Merz, Valeria, Casalino, Simona, Zecchetto, Camilla, Simionato, Francesca, Salt, Hayley Louise, Contarelli, Serena, Santoro, Raffaela, Melisi, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Gastric Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928085/ https://www.ncbi.nlm.nih.gov/pubmed/31897341 http://dx.doi.org/10.5230/jgc.2019.19.e39 |
Ejemplares similares
-
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial
por: Merz, Valeria, et al.
Publicado: (2020) -
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
por: Carbone, Carmine, et al.
Publicado: (2018) -
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
por: Merz, Valeria, et al.
Publicado: (2021) -
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
por: Merz, Valeria, et al.
Publicado: (2020) -
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
por: Gaule, Marina, et al.
Publicado: (2022)